Christine Mackenzie 5/27/25 Christine Mackenzie 5/27/25 Syndeio Biosciences Launches to Lead the Emerging Field of Synapse-Targeted Neurotherapeutics Read More Jamison Wright 2/19/25 Jamison Wright 2/19/25 Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience Read More Jamison Wright 12/12/24 Jamison Wright 12/12/24 Gate Neurosciences Presents New Data and Insights Highlighting Unique Pharmacology of Synaptic Function Modulators at the 2024 ACNP Annual Meeting Read More Jamison Wright 12/3/24 Jamison Wright 12/3/24 Gate Neurosciences and University of Pittsburgh Collaborate to Initiate Phase 2 Trial Combining Apimostinel with Digital Therapeutic for Depression Read More Jamison Wright 5/15/24 Jamison Wright 5/15/24 Gate Neurosciences to share new data and research on its synaptic function molecules with multiple posters at 2024 ASCP meeting Read More
Christine Mackenzie 5/27/25 Christine Mackenzie 5/27/25 Syndeio Biosciences Launches to Lead the Emerging Field of Synapse-Targeted Neurotherapeutics Read More
Jamison Wright 2/19/25 Jamison Wright 2/19/25 Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience Read More
Jamison Wright 12/12/24 Jamison Wright 12/12/24 Gate Neurosciences Presents New Data and Insights Highlighting Unique Pharmacology of Synaptic Function Modulators at the 2024 ACNP Annual Meeting Read More
Jamison Wright 12/3/24 Jamison Wright 12/3/24 Gate Neurosciences and University of Pittsburgh Collaborate to Initiate Phase 2 Trial Combining Apimostinel with Digital Therapeutic for Depression Read More
Jamison Wright 5/15/24 Jamison Wright 5/15/24 Gate Neurosciences to share new data and research on its synaptic function molecules with multiple posters at 2024 ASCP meeting Read More
